Min‐Hsiung Pan

Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions.

Ann‐Lii Cheng, Chih‐Hung Hsu, Jen‐Kou Lin et al. · PubMed · 2001 · 2.1K citations

Urinary Bladder Cancer, Chemopreventive Agent, Oncology +15

Stability of curcumin in buffer solutions and characterization of its degradation products

Ying‐Jan Wang, Min‐Hsiung Pan, Ann‐Lii Cheng et al. · Journal of Pharmaceutical and Biomedical Analysis · 1997 · 1.7K citations

Materials Science, Engineering, Green Chemistry +3

Biotransformation of Curcumin Through Reduction and Glucuronidation in Mice

Min‐Hsiung Pan, Tsang‐Miao Huang, Jen‐Kun Lin · Drug Metabolism and Disposition · 1999 · 932 citations

Comparative studies on the suppression of nitric oxide synthase by curcumin and its hydrogenated metabolites through down-regulation of IκB kinase and NFκB activation in macrophages

Min‐Hsiung Pan, Shoei‐Yn Lin‐Shiau, Jen‐Kun Lin · Biochemical Pharmacology · 2000 · 356 citations

Inflammation, Anti-inflammatory, Iκb Kinase +13

Chemistry and health effects of polymethoxyflavones and hydroxylated polymethoxyflavones

Shiming Li, Min‐Hsiung Pan, Chih‐Yu Lo et al. · Journal of Functional Foods · 2008 · 257 citations · Full text

Pmf Bioavailability, Medicinal Chemistry, Biochemistry +13